Imagen de Portada

Reduction of opioid and barbiturate use following initiation of rimegepant for migraine in the United States

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Noah Rosen, Aaron Jenkins, Karin Hygge Blakeman, Feng Dai, Lucy Abraham, Chelsea Leroue, Josh Brown
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Headache: The Journal of Head and Face Pain
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
por: Jessica Ailani, et al.
Publicado: (2024)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
por: David Kudrow, et al.
Publicado: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
por: Koichi Ikeda, et al.
Publicado: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
por: Larry Charleston, et al.
Publicado: (2026)

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine
por: Chay Ngee Lim, et al.
Publicado: (2025)

Prevalence and burden of migraine in the United States: A systematic review
por: Fred Cohen, et al.
Publicado: (2024)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
por: Shivang Joshi, et al.
Publicado: (2024)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
por: Christoph T. Berger, et al.
Publicado: (2026)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
por: Graham A. McLeod, et al.
Publicado: (2025)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
por: Richard B. Lipton, et al.
Publicado: (2025)

Association between obstructive sleep apnea and migraine: A United States population‐based cohort study
por: Thomas Yen‐Ting Chen, et al.
Publicado: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
por: Rikki Mangrum, et al.
Publicado: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
por: Yunus Emre Meydanal, et al.
Publicado: (2025)

Headache‐related disability as a function of migraine aura: A daily diary study
por: Delora E. Denney, et al.
Publicado: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
por: Fred Cohen, et al.
Publicado: (2025)

Evaluating associations of migraine‐related vertigo
por: Nazia Karsan, et al.
Publicado: (2025)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
por: Fred Cohen, et al.
Publicado: (2024)

Afterimage duration differs for migraine with or without aura
por: Florian Rimmele, et al.
Publicado: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
por: Rebecca Erwin Wells, et al.
Publicado: (2024)

Useful considerations for treating migraine in patients with autism
por: Sinifunanya E. Nwaobi
Publicado: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
por: Gabriel Camargo de Oliveira, et al.
Publicado: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
por: Shuu‐Jiun Wang, et al.
Publicado: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
por: Inga Zalia Tummoszeit, et al.
Publicado: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
por: Chia‐Chun Chiang, et al.
Publicado: (2024)

Counting the cost: How migraine shapes lives and economies
por: Risako Shirane, et al.
Publicado: (2025)

Cardiovascular risk and triptan usage among patients with migraine
por: Ido Peles, et al.
Publicado: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
por: Amy A. Gelfand
Publicado: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
por: Shiri Shinan‐Altman, et al.
Publicado: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
por: Richard B. Lipton, et al.
Publicado: (2026)

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
por: David W. Dodick, et al.
Publicado: (2025)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
por: Irene Patniyot, et al.
Publicado: (2024)

Chronotype in migraine and tension‐type headache: A population study
por: Da Eun Jung, et al.
Publicado: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
por: Raghavan Gopalakrishnan, et al.
Publicado: (2024)

Causal associations between genetically predicted placental weight and migraine
por: Chung‐Chih Liao, et al.
Publicado: (2025)

Time to reconsider the association between migraine and white matter hyperintensities?
por: Anders Hougaard
Publicado: (2025)

Investigating the causal and genetic relationship between migraine and Parkinson's disease
por: Ming‐Gang Deng, et al.
Publicado: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
por: Bilal Ahmed Rizvi, et al.
Publicado: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
por: Susan Hutchinson, et al.
Publicado: (2026)

The role of stress in the comorbidity of migraine and other chronic primary pain
por: Shi‐Jie Zhao, et al.
Publicado: (2025)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
por: Antonio Munafò, et al.
Publicado: (2026)